Abstract
Basic fibroblast growth factor (b-FGF) is one of the multifunctional growth factors with important therapeutic potential in the field of ophthalmology. It is also implicated in pathogenesis of vitreoretinal proliferative diseases. In the present study, we evaluated its vitreoretinal toxicity by means of clinical observation, electroretinography (ERG), and histopathology after injection of different doses of b-FGF into the vitreous of rabbit eyes. Doses of b-FGF up to 2 μg per eye caused no toxicity; however, injection of 4 μg or more resulted in sight-threatening vitreoretinal proliferative changes. This information is important for studies aimed at evaluating the therapeutic potential of b-FGF in retinal diseases.
Despite some degree of vitreous organization and opacification, retinal folds, and small areas of traction retinal detachment, the amplitudes of ERGs were normal or even increased (hyperpolarization) in eyes which received 8 μg of b-FGF.
Similar content being viewed by others
References
Baird A, Bohlen P. Fibroblast growth factors. In: ‘Handbook of experimental pharmacology’, Vol 95/I. Springer-Verlag, Berlin, pp 369–417, 1990.
Baird A, Esch F, Gospodarowicz D, Guillemin R. Retina-and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry 1985; 4:7855–60.
Beitz JG, Davol P, Clark JW et al. Antitumor activity of basic fibroblast growth factor-saporin mitotoxinin vitro andin vivo. Cancer Res 1992; 52: 227–30.
Bensaid M, Malecaze F, Prats H, Bayard F, Tauber JP. Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res 1989; 48: 801–13.
Bradshaw RA, Cavanaugh KP. Isolation and characterization of growth factors. In: 'Handbook of experimental pharmacology, Vol 95/I. Springer-Verlag, Berlin, pp 17–36, 1990.
Campochiaro PA, Glaser BM. A retina-derived stimulator (s) of retinal pigment epithelial cell and astrocyte proliferation. Exp Eye Res 1986; 43: 449–57.
Committee on care and use of laboratory animals. Guide for the care and use of laboratory animals. National Institute of Health, Bethesda, MD, USA. 1986; DHHS publ. No. (NIH) 86–23.
Connolly SE, Hjelmeland LM, LaVail MM. Localization of bFGF in developing retinas of normal and RCS rats. Invest Ophthalmol Vis Sci 1992; 32 (Suppl): 754.
Faktorovich E, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347: 83–6.
Ferguson IA, Schweitzer JB, Johnson EM Jr. Basic fibroblast growth factor: receptor-mediated internalization, metabolism, and anterograde axonal transport in retinal ganglion cells. J Neurosci 1990; 10: 2176–89.
Fredj-Reygrobellet D, Plouet J, Delayer T, Baudouin C, Bourret F, Lapalus P. Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr Eye Res 1987; 6:1205–9.
Gospodarowicz D, Massoglia S, Cheng J, Fujii DK. Effect of retina-derived basic and acidic fibroblast growth factor and lipoproteins on the proliferation of ratina-derived capillary endothelial cells. Exp Eye Res 1986; 43: 459–76.
Hagemen GS, Kirchoff-Rempe MA, Lewis GP, Fisher SK, Anderson DH. Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc Natl Acad Sci USA 1991; 88: 6706–10.
Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res 1988; 3:177–86.
Hanneken A, Dahl R, Farris J, Gonzalez AM, Baird A. In situ hybridization of the human fibroblast growth factor receptor (flg) in the human retina. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1299.
Hewitt AT, Lindsey JD, Carbbott D, Adler R. Photoreceptor survival promoting activity in interphotoreceptor matrix preparations: characterization and partial purification. Exp Eye Res 1990; 50:79–88.
Hicks D, Courtois Y. Fibroblast growth factor stimulates photoreceptor differentiationin vitro. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1298.
Hori S. Pathophysiology of intraocular neovascularization. Nippon Ganka Gakkai Zasshi 1990; 94:1103–21.
Ishiqooka H, Aotaki-Keen A, Hjelmland LM. Light and electron microscopic localization of basic FGF in the cat retina. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1299.
Kirchoff-Rempe MA, Hageman GS, Lewis GP, Fisher SK, Anderson K, Anderson DH. Association of immunoreactive basic fibroblast growth factor with the insoluble interphotoreceptor matrix. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1216.
Leschey KH, Hines J, Singer JH, Hackett SF, Campochiaro PA. Inhibition of growth factor effects in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1991; 32:1770–8.
Lewis GP, Guerin CJ, Erickson PA, Anderson DH, Fisher SK. Basic fibroblast growth factor (bFGF) stimulates proliferation of non-neuronal retinal cellsin vivo. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 754.
Park CM, Hollenberg MG. Basic fibroblast growth factor induced retinal regenerationin vivo. Devel Biol 1989; 134: 201–5.
Pittack C, Jones M, Reh TA. Basic fibroblast growth factor induces retinal pigment epithelium to generate neural retinain vitro. Development 1991; 1213: 577–88.
Rubinson K. Distribution of basic fibroblast growth factor in developing lamprey retina. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1299.
Schuschereba ST, Bowman PD, Lund DJ et al. Basic fibroblast growth factor acceleration of repair of argon laser lesions in rabbit retina. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 914.
Schweigerer L, Malerstein B, Neufeld G, Gospodarowicz D. Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun 1987; 143: 934–40.
Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990; 108: 869–72.
Soubrane G, Cohen SY, Delayre T, Courtois Y, Coscas G, Jeanny JC. Experimental model of bFGF induced subretinal angiogenesisin vivo. Invest Ophthalmol Vis Sci 1991; 32 (Suppl): 1299.
Sporn MB, Roberts AB. Peptide growth factors and their receptors. In: ‘Handbook of experimental pharmacology’. Vol 95/I. Springer-Verlag, Berlin, pp 3–15, 1990.
Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992; 36:373–84.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borhani, H., Peyman, G.A., Rahimy, M.H. et al. Vitreoretinal toxicity of basic fibroblast growth factor. Int Ophthalmol 17, 195–199 (1993). https://doi.org/10.1007/BF01007740
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01007740